U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07490769) titled 'Levetiracetam Three Times Daily in Epilepsy' on March 11.
Brief Summary: The purpose of this clinical trial is to evaluate the efficacy and tolerability of Levetiracetam administered three times daily in patients with epilepsy. The primary objective is to investigate whether orally administered Levetiracetam three times daily dosing is superior in seizure-free days compared to standard twice-daily dosing in patients with epilepsy.
Key questions include:
* Does LEV improve seizure control, as measured by seizure-free days?
* What adverse events or safety concerns are observed with LEV treatment?
Participants will receive Levetir...